Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Autonomous Synthesis of Fluorescent Silica Biodots Using Engineered Fusion Proteins.

Olmez TT, Yuca E, Eyupoglu E, Catalak HB, Sahin O, Seker UOS.

ACS Omega. 2018 Jan 31;3(1):585-594. doi: 10.1021/acsomega.7b01769. Epub 2018 Jan 18.

2.

Self-assembly of bacterial amyloid protein nanomaterials on solid surfaces.

Onur T, Yuca E, Olmez TT, Seker UOS.

J Colloid Interface Sci. 2018 Jun 15;520:145-154. doi: 10.1016/j.jcis.2018.03.016. Epub 2018 Mar 7.

PMID:
29533854
3.

A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors.

Evans KW, Yuca E, Akcakanat A, Scott SM, Arango NP, Zheng X, Chen K, Tapia C, Tarco E, Eterovic AK, Black DM, Litton JK, Yap TA, Tripathy D, Mills GB, Meric-Bernstam F.

Clin Cancer Res. 2017 Nov 1;23(21):6468-6477. doi: 10.1158/1078-0432.CCR-17-0615.

PMID:
29093017
4.

Biosilver nanoparticle interface offers improved cell viability.

VanOosten SK, Yuca E, Karaca BT, Boone K, Snead ML, Spencer P, Tamerler C.

Surf Innov. 2016 Sep;4(3):121-132. doi: 10.1680/jsuin.16.00010. Epub 2016 Nov 7.

5.

Engineered Peptide Repairs Defective Adhesive-Dentin Interface.

Ye Q, Spencer P, Yuca E, Tamerler C.

Macromol Mater Eng. 2017 May;302(5). pii: 1600487. doi: 10.1002/mame.201600487. Epub 2017 Feb 15.

6.

Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer.

Arango NP, Yuca E, Zhao M, Evans KW, Scott S, Kim C, Gonzalez-Angulo AM, Janku F, Ueno NT, Tripathy D, Akcakanat A, Naing A, Meric-Bernstam F.

Breast Cancer Res. 2017 Aug 15;19(1):93. doi: 10.1186/s13058-017-0878-6.

7.

The ZNF304-integrin axis protects against anoikis in cancer.

Aslan B, Monroig P, Hsu MC, Pena GA, Rodriguez-Aguayo C, Gonzalez-Villasana V, Rupaimoole R, Nagaraja AS, Mangala S, Han HD, Yuca E, Wu SY, Ivan C, Moss TJ, Ram PT, Wang H, Gol-Chambers A, Ozkayar O, Kanlikilicer P, Fuentes-Mattei E, Kahraman N, Pradeep S, Ozpolat B, Tucker S, Hung MC, Baggerly K, Bartholomeusz G, Calin G, Sood AK, Lopez-Berestein G.

Nat Commun. 2015 Jun 17;6:7351. doi: 10.1038/ncomms8351.

8.

Coupling Infusion and Gyration for the Nanoscale Assembly of Functional Polymer Nanofibers Integrated with Genetically Engineered Proteins.

Zhang S, Karaca BT, VanOosten SK, Yuca E, Mahalingam S, Edirisinghe M, Tamerler C.

Macromol Rapid Commun. 2015 Jul;36(14):1322-8. doi: 10.1002/marc.201500174. Epub 2015 Jun 1.

9.

STAMP2 increases oxidative stress and is critical for prostate cancer.

Jin Y, Wang L, Qu S, Sheng X, Kristian A, Mælandsmo GM, Pällmann N, Yuca E, Tekedereli I, Gorgulu K, Alpay N, Sood A, Lopez-Berestein G, Fazli L, Rennie P, Risberg B, Wæhre H, Danielsen HE, Ozpolat B, Saatcioglu F.

EMBO Mol Med. 2015 Mar;7(3):315-31. doi: 10.15252/emmm.201404181.

10.

Antagonism of tumoral prolactin receptor promotes autophagy-related cell death.

Wen Y, Zand B, Ozpolat B, Szczepanski MJ, Lu C, Yuca E, Carroll AR, Alpay N, Bartholomeusz C, Tekedereli I, Kang Y, Rupaimoole R, Pecot CV, Dalton HJ, Hernandez A, Lokshin A, Lutgendorf SK, Liu J, Hittelman WN, Chen WY, Lopez-Berestein G, Szajnik M, Ueno NT, Coleman RL, Sood AK.

Cell Rep. 2014 Apr 24;7(2):488-500. doi: 10.1016/j.celrep.2014.03.009. Epub 2014 Apr 3.

11.

Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (-) and ER (+) Breast Cancer.

Tekedereli I, Alpay SN, Akar U, Yuca E, Ayugo-Rodriguez C, Han HD, Sood AK, Lopez-Berestein G, Ozpolat B.

Mol Ther Nucleic Acids. 2013 Sep 10;2:e121. doi: 10.1038/mtna.2013.45.

12.

Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer.

Jin Y, Qu S, Tesikova M, Wang L, Kristian A, Mælandsmo GM, Kong H, Zhang T, Jerónimo C, Teixeira MR, Yuca E, Tekedereli I, Gorgulu K, Alpay N, Sood AK, Lopez-Berestein G, Danielsen HE, Ozpolat B, Saatcioglu F.

Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):E2572-81. doi: 10.1073/pnas.1304318110. Epub 2013 Jun 24.

13.

Addressable self-immobilization of lactate dehydrogenase across multiple length scales.

Cetinel S, Caliskan HB, Yucesoy DT, Donatan AS, Yuca E, Urgen M, Karaguler NG, Tamerler C.

Biotechnol J. 2013 Feb;8(2):262-72. doi: 10.1002/biot.201100502.

PMID:
23386458
14.

Highly specific targeting of the TMPRSS2/ERG fusion gene using liposomal nanovectors.

Shao L, Tekedereli I, Wang J, Yuca E, Tsang S, Sood A, Lopez-Berestein G, Ozpolat B, Ittmann M.

Clin Cancer Res. 2012 Dec 15;18(24):6648-57. doi: 10.1158/1078-0432.CCR-12-2715. Epub 2012 Oct 10.

15.

Multifunctional protein-enabled patterning on arrayed ferroelectric materials.

Hnilova M, Liu X, Yuca E, Jia C, Wilson B, Karatas AY, Gresswell C, Ohuchi F, Kitamura K, Tamerler C.

ACS Appl Mater Interfaces. 2012 Apr;4(4):1865-71. doi: 10.1021/am300177t. Epub 2012 Apr 3.

PMID:
22458431
16.

Expression characteristics of ARF1 and SAR1 during development and the de-etiolation process.

Keskin BC, Yuca E, Ertekin O, Yüksel B, Memon AR.

Plant Biol (Stuttg). 2012 Jan;14(1):24-32. doi: 10.1111/j.1438-8677.2011.00482.x. Epub 2011 Jul 4.

PMID:
21973219
17.

In vitro labeling of hydroxyapatite minerals by an engineered protein.

Yuca E, Karatas AY, Seker UO, Gungormus M, Dinler-Doganay G, Sarikaya M, Tamerler C.

Biotechnol Bioeng. 2011 May;108(5):1021-30. doi: 10.1002/bit.23041. Epub 2011 Jan 28.

PMID:
21190171

Supplemental Content

Support Center